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Introduction
Tuberculosis (TB) pleurisy is the main extrapulmonary
presentation of TB secondary to TB lymphadenitis.1
If TB pleurisy is left untreated, the pleural effusion will
usually resolve spontaneously, however, pulmonary or
extrapulmonary TB within the subsequent 5 years will
develop in approximately 65% of patients.2 Diagnosis
of TB pleurisy is usually accomplished with radiologic
and clinical findings, pathology of pleural tissue from
biopsy, and several laboratory methods. Conventional
methods include direct examination of pleural fluid with
Ziehl-Neelsen staining of acid-fast bacilli and culture.
Ziehl-Neelsen staining is rapid and inexpensive but
requires bacillar concentration of 10,000/mL and has
a low sensitivity of approximately 0–1%.3,4
Culture is more sensitive (11–50%);5,6 only 10–100
bacilli yield to the diagnosis, but require 2–6 weeks to
grow Mycobacterium tuberculosis. Pleural biopsy has
high sensitivity (70–80%),3,4,7 but the procedure is not
free of risk. Polymerase chain reaction (PCR) is a molec-
ular biology technique that can detect M. tuberculosis
genome in pleural fluid or tissue specimens. The sen-
sitivity (31.3–81%) and specificity (96.6–100%) are
variable.8–10 A recent study suggests that PCR has a
potential role in confirmation of TB pleurisy but may
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not be useful in excluding the disease.11 We report
our experience with an in-house IS6110-based nested
PCR assay for diagnosis of TB pleurisy.
Methods
Patients
The study comprised 212 patients with negative acid-
fast pleural effusion smears who were suspected to have
TB pleurisy and who had undergone TB PCR study
in Taipei Veterans General Hospital between January
2002 and November 2003. TB pleurisy was defined
as when at least 1 of the following criteria were met:
(1) chronic granulomatous inflammation with or with-
out caseous necrosis is found on pleural biopsy; (2)
M. tuberculosis is cultured from pleural effusion; (3)
compatible clinical symptoms and signs with good anti-
TB treatment response are found. Forty-nine patients
with undetermined etiology were excluded, and a total
of 163 patients including 53 with TB pleurisy and
110 with non-TB pleurisy were enrolled in the study.
Pleural effusion samples
For each subject, at least 30 mL of pleural fluid was
collected in a syringe during thoracentesis. The resus-
pended pellets were submitted for acid-fast staining, and
innoculated (0.1 mL) on Lowenstein–Jensen medium
at 37°C and assessed weekly for mycobacterial growth
for a total of 8 weeks. The remainder of pellets was
tested by an in-house nested PCR assay. TB was iden-
tified by a positive niacin test result.
Nested PCR assay
The suspended pellets were washed twice with 0.5–1mL
of TEX (Tris-EDTA-Triton X-100) lysis buffer con-
sisting of 1% Triton X-100 in 10 mM Tris-EDTA
(10 mM Tris/HCl, pH 8.0, and 1 mM EDTA) and
was sedimented by centrifugation at 12,500g for 5
minutes. Each sediment was suspended in 100 μL of
TEX lysis buffer, and the mixture was incubated at
95°C for 30 minutes to break down the bacterial cell
walls and to release the DNA for subsequent nested
PCR amplification. Ten microliters of clinical sample
was amplified by the in-house nested PCR assay with
IS6110-specific primers. The outer primers were INS1
and INS2, as described previously.12 The inner primers
were the sense primer (5′-AGATGCACCGTCGAA-
CGG-3′) and the antisense primer (5′-GCCACGTAG-
GCGAACCCTG-3′), corresponding to the base pairs
652–668 and 836–854, respectively. Briefly, using the
outer primers, the DNA samples were added to 15μL of
the master reaction mixture containing 1.5mM MgCl2,
10 mM Tris/HCL, 0.1% Triton X-100, 50 mM KCl,
200 μM of each deoxyribonucleotide triphosphate,
0.5 μM of each outer primer, and 0.5 U of Taq poly-
merase (Ampli Taq; Perkin Elmer, Cetus, Norwalk, CT,
USA). After denaturation at 94°C for 5 minutes, the
mixture was subjected to 30 cycles of denaturation at
94°C for 1 minute, annealing at 65°C for 2 minutes,
and primer extension at 72°C for 5 minutes. For the
nested PCR, 75μL of the same master reaction mixture
containing 0.5 μM each of inner primer and 2.5 U of
Taq polymerase were added to the previous PCR prod-
uct in a final volume of 100 μL. The nested PCR was
carried out for 30 cycles under the same amplification
conditions, with the omission of the terminal primer
extension. Amplification was done in the GeneAmp
PCR system 9,600 thermal cycles (Perkin Elmer Applied
Biosystems). The PCR products (203bp) were analyzed
by 2% NuSieve 3:1 agarose (FMC, Rockland, MD,
USA) gel electrophoresis.
Statistical analysis
We compared demographic categorical data using χ2
or Fisher’s exact test, and continuous data using the
Mann-Whitney U test. We assumed statistical signifi-
cance at p < 0.05. The sensitivity, specificity, positive
predictive value, and negative predictive value of PCR
were calculated to predict TB pleurisy occurrence.
Results
We studied 163 patients with negative acid-fast pleu-
ral effusion smears; 53 patients were diagnosed with 
TB pleurisy. Among these 53 cases, 14 had chronic
granulomatous inflammation with good anti-TB treat-
ment response, 1 had chronic granulomatous inflam-
mation with caseous necrosis, 15 had M. tuberculosis
cultured from pleural effusion, and 26 had compati-
ble clinical symptoms and signs with good anti-TB
treatment response. One-hundred and ten patients did
not have TB, including 42 para-pneumonic effusions,
1 virus-related pleural effusion, 28 malignant pleural
effusions, 14 congestive heart failure-related effusions,
4 chylous effusions, 3 SLE-related effusions, 1 colla-
gen vascular disease-related effusion, 15 other transu-
date pleural effusions, and 1 hypothyroidism-related
effusion (Table 1). PCR for M. tuberculosis DNA, done
on the pleural effusions, was positive in 23 (43.4%) of
53 TB pleurisy patients, and in 5 (4.5%) of 110 non-TB
pleurisy patients. In the 53 TB pleurisy cases, culture
of pleural effusion was positive in 15 (28.3%), and it was
negative for all 110 non-TB pleurisy cases. The nested
PCR for M. tuberculosis DNA was 43.4% sensitive and
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95.5% specific, having a positive predictive value of
82% and negative predictive value of 77.7%.
Among the 53 TB pleurisy patients, 27 received
pleural biopsy; chronic granulomatous inflammation
with or without caseous necrosis was found in 15
(55.6%) of the 27 patients with pleural biopsy. Of these
27 patients, PCR and culture of pleural fluid was pos-
itive in 12 (44.4%) and 3 (11.1%) patients, respectively.
Among 12 of 27 TB pleurisy patients without granu-
lomatous inflammation, PCR was positive in 4 patients.
A higher proportion (19 patients, 70.4%) of patients
with TB pleurisy was diagnosed when PCR was com-
bined with biopsy results (Table 2).
Discussion
TB pleurisy is the main extrapulmonary TB presenta-
tion secondary to TB lymphadenitis.1 If TB pleurisy 
is left untreated, pleural effusion will usually resolve
spontaneously; however, pulmonary or extrapulmonary
TB within the subsequent 5 years will develop in approx-
imately 65% of cases.2 As in other high-incidence
areas of TB, TB pleurisy is the most common etiology
of pleural effusion (25%), other than malignancy,
para-pneumonic effusion, and congestive heart failure.13
Taiwan is also an area with high TB incidence. Thus,
TB pleurisy should be ruled out in patients with un-
diagnosed exudative pleural effusions. Considerable
advances have been made in improving the speed of
detection of mycobacterium using PCR techniques.
We have shown PCR amplification to be sensitive and
specific for the rapid detection of TB bacilli DNA 
in respiratory specimens, and demonstrated a high
sensitivity and specificity of 91.7% and 98.6%, respec-
tively.14 However, TB pleurisy remains a diagnostic
challenge. Pleural fluid staining for acid-fast bacilli
and culture of M. tuberculosis has a poor yield. We
currently perform this assay for the detection of pleural
TB with negative acid-fast smears. In this study, based
on the final diagnosis, we found that PCR assay was
more sensitive than microbiologic tests and cultures
of pleural fluid in the diagnosis of smear-negative TB
pleurisy, where almost half of the cases of treatment
began without substantiation of diagnosis. However,
the limitation of relying on PCR alone is the low sen-
sitivity (43.4%) yield due to the low number of TB
bacilli in the pleural fluid, which was demonstrated by
the low culture (28.3%) yield from pleural fluid. Others
have reported experiences of PCR amplification with
pleural fluid and found them only positive in 17.1% of
TB pleurisy, and positive culture in 24.6% of patients
with TB pleurisy.15 Previous reports of PCR speci-
ficity ranged from 95.4 to 100%.16–18 The specificity
of our PCR result was 95.5%, with 5 of 110 non-TB
pleurisy cases demonstrating positive PCR examination.
However, only 1 of these 5 patients received pleural
biopsy, and 1 had previous TB history. Diagnosis of TB
pleurisy in these 5 patients may be underestimated.
Of 27 patients with pleural biopsy, PCR and cul-
ture of pleural fluid was positive in 12 (44.4%) and 
3 (11.1%) patients, respectively. Among 12 of 27 TB
pleurisy patients without granulomatous inflammation,
Table 1. Demographic data of 163 patients
TB pleurisy (n = 53) Non-TB pleurisy (n = 110) p
Sex, n (%) 0.087
Male 44 (83) 80 (72.7)
Female 9 (17) 30 (27.3)
Median age, yr 76 78 0.708
Pleural effusion samples, n (%)
Positive PCR 23 (43.4)* 5 (4.5) < 0.001
Positive Ziehl-Neelsen stain 0 0
Positive TB culture 15 (28.3) 0 (0) < 0.001
*Seven in 15 positive TB culture, 16 in 38 negative TB culture.
Table 2. Diagnostic methods in 27 patients who received pleural
biopsy in the TB pleurisy group
Diagnostic method n Sensitivity (%)
Effusion culture 3 11.10
Effusion PCR 12 44.40
Pleural biopsy 15 55.50
Effusion PCR + 14 51.90
effusion culture
Effusion PCR + 19 70.30
pleural biopsy
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PCR was positive in 4 patients. A higher proportion
(70.4%) of patients with TB pleurisy was diagnosed
when PCR was combined with biopsy results.
In conclusion, although PCR used in this study had
a higher sensitivity than other diagnostic options, using
PCR alone is not sensitive enough for rapid diagnosis
of TB pleurisy. However, for patients with a typical
clinical presentation for TB pleurisy, it can still play an
important role in early detection of nondiagnostic ex-
udative pleural effusion with negative acid-fast smear,
especially when combined with pleural biopsy pre-
senting chronic granulomatous inflammation with or
without caseous necrosis.
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